LAWRENCE CHARLES MADOFF, MD
Osteopathic Medicine in Worcester, MA
License number
Massachusetts 55471
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2
55 N Infectious DEPARTMENT DISEASE, Worcester, MA 01655
PO Box 415348, Boston, MA 02241
PO Box 415348, Boston, MA 02241
Phone
(508) 856-1720
Personal information
See more information about LAWRENCE CHARLES MADOFF at radaris.comName
Address
Phone
15 Coolidge St, Brookline, MA 02446
15 Coolidge Ave, Watertown, MA 02472
15 Coolidge St, Brookline, MA 02446
15 Follen St, Boston, MA 02116
Professional information
See more information about LAWRENCE CHARLES MADOFF at trustoria.com
Lawrence Charles Madoff, Worcester MA
Lawrence Charles Madoff, Worcester MA
Specialties:
Infectious Disease Specialist
Address:
55 Lake Ave N, Worcester, MA 01655
Education:
Tufts University, School of Medicine - Doctor of Medicine*
Brigham & Women's Hospital - Fellowship - Infectious Disease (Internal Medicine)*
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Internal Medicine*
Brigham & Women's Hospital - Fellowship - Infectious Disease (Internal Medicine)*
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)*
Dr. Lawrence C Madoff, Worcester MA - MD (Doctor of Medicine)
Dr. Lawrence C Madoff, Worcester MA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
Umass Mem Med Grp ID
55 Lake Ave N, Worcester 01655
(508) 856-3158 (Phone)
55 Lake Ave N, Worcester 01655
(508) 856-3158 (Phone)
Certifications:
Infectious Disease, 1988, Internal Medicine, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Umass Mem Med Grp ID
55 Lake Ave N, Worcester 01655
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Brigham and Women's Hospital
75 Francis St, Boston 02115
55 Lake Ave N, Worcester 01655
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
Tufts University
Graduated: 1982
New York Presbyterian Hospital-New York Weill Cornell Center
Brigham and Womens Hospital
Tufts University
Graduated: 1982
New York Presbyterian Hospital-New York Weill Cornell Center
Brigham and Womens Hospital
Lawrence C Madoff, Worcester MA
Lawrence C Madoff, Worcester MA
Specialties:
Internal Medicine, Infectious Disease
Work:
U Mass Memorial Medical Center
55 Lake Ave N, Worcester, MA 01655 Harvard University
181 Longwood Ave, Boston, MA 02115
55 Lake Ave N, Worcester, MA 01655 Harvard University
181 Longwood Ave, Boston, MA 02115
Education:
Tufts University (1982)
Immunogenic Composition For Group B Streptococcus
Immunogenic Composition For Group B Streptococcus
US Patent:
6342223, Jan 29, 2002
Filed:
Jul 20, 1999
Appl. No.:
09/346290
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corporation Brigham and Womens Hospital - Boston MA
International Classification:
A61K 3909
US Classification:
4241901, 530350
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B. The vaccine provides polysaccharide-protein moieties and contain (a) a group B polysaccharide conjugated to (b) a functional derivative of a group B C protein alpha antigen that retains the ability to elicit protective antibodies against group B. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Conjugate Vaccine For Group B Streptococcus
Conjugate Vaccine For Group B Streptococcus
US Patent:
5847081, Dec 8, 1998
Filed:
Jun 5, 1995
Appl. No.:
8/462679
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corp. - Charlestown MA
The Brigham and Women's Hospital - Boston MA
The Brigham and Women's Hospital - Boston MA
International Classification:
C07K 14315, C12N 120
US Classification:
530350
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Conjugate Vaccine For Group B Streptococcus
Conjugate Vaccine For Group B Streptococcus
US Patent:
5820860, Oct 13, 1998
Filed:
Jun 5, 1995
Appl. No.:
8/463288
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corp. - Charlestown MA
The Brigham and Women's Hospital - Boston MA
The Brigham and Women's Hospital - Boston MA
International Classification:
A61K 3940, A61K 39385, C07K 110
US Classification:
4241651
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b)) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Conjugate Vaccine For Group B Streptococcus
Conjugate Vaccine For Group B Streptococcus
US Patent:
5843444, Dec 1, 1998
Filed:
Jun 6, 1995
Appl. No.:
8/470445
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corporation - Boston MA
Brigham and Women's Hospital - Boston MA
Brigham and Women's Hospital - Boston MA
International Classification:
A61K 3940, A61K 39385, A61K 3909, C07K 104
US Classification:
4241651
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Conjugate Vaccine Against Group B Streptococcus
Conjugate Vaccine Against Group B Streptococcus
US Patent:
5648241, Jul 15, 1997
Filed:
Dec 22, 1994
Appl. No.:
8/363311
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corporation - Charlestown MA
Brigham and Women's Hospital - Boston MA
Brigham and Women's Hospital - Boston MA
International Classification:
C12P 2102, C12N 120, C12N 1500, C07H 2104
US Classification:
435 693
Abstract:
A purified DNA molecule is disclosed that comprises a DNA sequence encoding a Group B Streptococcus alpha antigen or antibody eliciting fragment. The alpha antigen sequence encodes several distinct domains including an N-terminal sequence that precedes the start of the alpha antigen repeating sequence, a C-terminal anchor sequence and a repeating unit motif. The ability to protect mice against a Streptococcus infection with antisera against cellular extracts containing the alpha antigen encoded by the DNA molecule was determined.
Conjugate Vaccine For Group B Streptococcus
Conjugate Vaccine For Group B Streptococcus
US Patent:
5968521, Oct 19, 1999
Filed:
Jun 5, 1995
Appl. No.:
8/469014
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corporation - Boston MA
Brigham and Women's Hospital - Boston MA
Brigham and Women's Hospital - Boston MA
International Classification:
A61K 39385, A61K 3909, C07K 104
US Classification:
42419711
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.
Conjugate Vaccine For Group B Streptococcus
Conjugate Vaccine For Group B Streptococcus
US Patent:
5858362, Jan 12, 1999
Filed:
Jun 6, 1995
Appl. No.:
8/466210
Inventors:
James L. Michel - Waban MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Dennis L. Kasper - Newton Centre MA
Frederick M. Ausubel - Newton MA
Lawrence C. Madoff - Boston MA
Assignee:
The General Hospital Corporation - Boston MA
Brigham and Women's Hospital - Boston MA
Brigham and Women's Hospital - Boston MA
International Classification:
A61K 3940, A61K 39385, C07K 104
US Classification:
4241651
Abstract:
A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysaccharide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of unit.